Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Sartans are a group of pharmaceuticals that modulate the renin–angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure), diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure. They block the activation of AT1receptors, preventing the binding of angiotensin II.
The report details the trend, potential and market size of Sartans market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Sartansmarket, defines the market attractiveness level of Sartans market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Sartans industry, describes the types of Sartans market, the applications of major players and the market size, and deeply analyzes the current situation of the global Sartans market and the development prospects and opportunities of Sartans industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Sartans market in Chapter 13.
By Player:
Bayer
Bristol-Myers Squibb
Eli Lilly and Company
Pfizer
Astra Zeneca
Jhonson and Johnson
GSK
Merck
Sanofi SA
Teva Pharmaceutical
Novartis
By Type:
Valsartan
Telmisartan
Losartan
Irbesartan
Azilsartan
Olmesartan
By End-User:
Hypertension
Cardiovascular Diseases
Kidney Diseases
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Sartans Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Sartans Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Sartans Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Sartans Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Sartans Market Analysis and Outlook to 2022
-
7.1 Global Sartans Consumption (2017-2022)
-
7.2 United States Sartans Consumption (2017-2022)
-
7.3 Europe Sartans Consumption (2017-2022)
-
7.4 China Sartans Consumption (2017-2022)
-
7.5 Japan Sartans Consumption (2017-2022)
-
7.6 India Sartans Consumption (2017-2022)
-
7.7 South Korea Sartans Consumption (2017-2022)
8 Region and Country-wise Sartans Market Analysis and Outlook to 2028
-
8.1 Global Sartans Consumption Forecast (2022-2028)
-
8.2 United States Sartans Consumption Forecast (2022-2028)
-
8.3 Europe Sartans Consumption Forecast (2022-2028)
-
8.4 China Sartans Consumption Forecast (2022-2028)
-
8.5 Japan Sartans Consumption Forecast (2022-2028)
-
8.6 India Sartans Consumption Forecast (2022-2028)
-
8.7 South Korea Sartans Consumption Forecast (2022-2028)
9 Global Sartans Market Outlook by Types and Applications to 2022
-
9.1 Global Sartans Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Valsartan Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Telmisartan Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Losartan Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Irbesartan Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Azilsartan Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Olmesartan Consumption and Growth Rate (2017-2022)
-
9.2 Global Sartans Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hypertension Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Kidney Diseases Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Sartans Market Outlook by Types and Applications to 2028
-
10.1 Global Sartans Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Valsartan Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Telmisartan Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Losartan Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Irbesartan Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Azilsartan Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Olmesartan Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Sartans Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hypertension Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Kidney Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Sartans Import and Export Analysis (Top 5 Countries)
-
11.1 Global Sartans Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Sartans Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Sartans Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Sartans Market Competitive Analysis
-
14.1 Bayer
-
14.1.1 Bayer Company Details
-
14.1.2 Bayer Sartans Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Bayer Sartans Product and Service
-
14.2 Bristol-Myers Squibb
-
14.2.1 Bristol-Myers Squibb Company Details
-
14.2.2 Bristol-Myers Squibb Sartans Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bristol-Myers Squibb Sartans Product and Service
-
14.3 Eli Lilly and Company
-
14.3.1 Eli Lilly and Company Company Details
-
14.3.2 Eli Lilly and Company Sartans Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Eli Lilly and Company Sartans Product and Service
-
14.4 Pfizer
-
14.4.1 Pfizer Company Details
-
14.4.2 Pfizer Sartans Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Pfizer Sartans Product and Service
-
14.5 Astra Zeneca
-
14.5.1 Astra Zeneca Company Details
-
14.5.2 Astra Zeneca Sartans Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Astra Zeneca Sartans Product and Service
-
14.6 Jhonson and Johnson
-
14.6.1 Jhonson and Johnson Company Details
-
14.6.2 Jhonson and Johnson Sartans Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Jhonson and Johnson Sartans Product and Service
-
14.7 GSK
-
14.7.1 GSK Company Details
-
14.7.2 GSK Sartans Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 GSK Sartans Product and Service
-
14.8 Merck
-
14.8.1 Merck Company Details
-
14.8.2 Merck Sartans Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Merck Sartans Product and Service
-
14.9 Sanofi SA
-
14.9.1 Sanofi SA Company Details
-
14.9.2 Sanofi SA Sartans Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Sanofi SA Sartans Product and Service
-
14.10 Teva Pharmaceutical
-
14.10.1 Teva Pharmaceutical Company Details
-
14.10.2 Teva Pharmaceutical Sartans Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Teva Pharmaceutical Sartans Product and Service
-
14.11 Novartis
-
14.11.1 Novartis Company Details
-
14.11.2 Novartis Sartans Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Novartis Sartans Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Sartans
-
Figure Sartans Picture
-
Table Global Sartans Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Sartans Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Sartans Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Sartans Consumption by Country (2017-2022)
-
Figure United States Sartans Consumption and Growth Rate (2017-2022)
-
Table Europe Sartans Consumption and Growth Rate (2017-2022)
-
Figure China Sartans Consumption and Growth Rate (2017-2022)
-
Figure Japan Sartans Consumption and Growth Rate (2017-2022)
-
Figure India Sartans Consumption and Growth Rate (2017-2022)
-
Figure South Korea Sartans Consumption and Growth Rate (2017-2022)
-
Figure Global Sartans Consumption Forecast by Country (2022-2028)
-
Figure United States Sartans Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Sartans Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Sartans Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Sartans Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Sartans Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Sartans Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Valsartan Consumption and Growth Rate (2017-2022)
-
Figure Global Telmisartan Consumption and Growth Rate (2017-2022)
-
Figure Global Losartan Consumption and Growth Rate (2017-2022)
-
Figure Global Irbesartan Consumption and Growth Rate (2017-2022)
-
Figure Global Azilsartan Consumption and Growth Rate (2017-2022)
-
Figure Global Olmesartan Consumption and Growth Rate (2017-2022)
-
Figure Global Hypertension Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Kidney Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Valsartan Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Telmisartan Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Losartan Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Irbesartan Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Azilsartan Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Olmesartan Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hypertension Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kidney Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Sartans Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Sartans Export by Region (Top 5 Countries) (2017-2028)
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Sartans Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Sartans Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Sartans Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Sartans Product and Service
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Sartans Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Sartans Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Sartans Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Sartans Product and Service
-
Table Astra Zeneca (Foundation Year, Company Profile and etc.)
-
Table Astra Zeneca Sartans Sales, Price, Value and Gross Profit (2017-2022)
-
Table Astra Zeneca Sartans Product and Service
-
Table Jhonson and Johnson (Foundation Year, Company Profile and etc.)
-
Table Jhonson and Johnson Sartans Sales, Price, Value and Gross Profit (2017-2022)
-
Table Jhonson and Johnson Sartans Product and Service
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK Sartans Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Sartans Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Sartans Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Sartans Product and Service
-
Table Sanofi SA (Foundation Year, Company Profile and etc.)
-
Table Sanofi SA Sartans Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi SA Sartans Product and Service
-
Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Sartans Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Sartans Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Sartans Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Sartans Product and Service
-
